World's Best Scientists 2026 revealed!
Mark X. Sliwkowski

Mark X. Sliwkowski

D-Index & Metrics

Biology and Biochemistry

D-Index
77
Citations
45666
World Ranking
4668
National Ranking
2261

Mark X. Sliwkowski publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Mark X. Sliwkowski sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 160 publications — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Mark X. Sliwkowski D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Mark X. Sliwkowski sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 77 D-Index — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Mark X. Sliwkowski is a researcher affiliated with Genentech in the United States, focusing primarily on medicine with a specialization in oncology and radiology, nuclear medicine, and imaging.

The scientist's recent publication record includes work on HER2-directed therapies in cancer treatment. Their most notable recent paper is titled "The HER2-directed antibody-drug conjugate DHES0815A in advanced and/or metastatic breast cancer: preclinical characterization and phase 1 trial results," published in 2024 in Nature Communications. This paper has received citations in the field.

The main fields of study for Mark X. Sliwkowski are medicine, with a total of three publications. Subfields include oncology, which accounts for two publications, and radiology, nuclear medicine, and imaging, with one publication.

Key research topics explored include:

  • HER2/EGFR in Cancer Research
  • Monoclonal and Polyclonal Antibodies Research
  • Cancer Treatment and Pharmacology

Frequent coauthors with whom they have collaborated include:

  • Gail D. Lewis Phillips
  • Guangmin Li
  • Jun Guo
  • Shang-Fan Yu
  • Carter T. Fields

Mark X. Sliwkowski's research has been published in venues such as:

  • Nature Communications

Best Publications

  • Untangling the ErbB signalling network

    Yosef Yarden;Mark X. Sliwkowski

  • Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate

    Gail D. Lewis Phillips;Guangmin Li;Debra L. Dugger;Lisa M. Crocker

  • Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor.

    Jennifer Stamos;Mark X. Sliwkowski;Charles Eigenbrot

  • Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index

    Jagath R Junutula;Helga Raab;Suzanna Clark;Sunil Bhakta

  • Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex

    Matthew C Franklin;Kendall D Carey;Felix F Vajdos;Daniel J Leahy

  • Identification of heregulin, a specific activator of p185erbB2.

    William E. Holmes;Mark X. Sliwkowski;Robert W. Akita;William J. Henzel

  • An Open-and-Shut Case? Recent Insights into the Activation of EGF/ErbB Receptors

    Antony W. Burgess;Hyun Soo Cho;Hyun Soo Cho;Charles Eigenbrot;Kathryn M. Ferguson

  • conjugado de anticorpo-droga, composição farmacêutica, artigo de manufatura e uso de um conjugado de anticorpo-droga

    Allen J Ebens;Brian E Toki;Mark X Sliwkowski;Paul Polakis

  • Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth.

    David B Agus;Robert W Akita;William D Fox;Gail D Lewis

  • Treatment of HER2-positive breast cancer: current status and future perspectives

    Carlos L. Arteaga;Mark X. Sliwkowski;C. Kent Osborne;Edith A. Perez

  • Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates

    Ben-Quan Shen;Keyang Xu;Luna Liu;Helga Raab

  • Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin).

    Sliwkowski Mx;Lofgren Ja;Lewis Gd;Hotaling Te

  • Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941

    Teemu T. Junttila;Robert W. Akita;Kathryn Parsons;Carter Fields

  • Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin.

    M.X. Sliwkowski;G. Schaefer;R.W. Akita;J.A. Lofgren

  • HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.

    Pietras Rj;Arboleda J;Reese Dm;Wongvipat N

  • Inhibitory effects of combinations of HER-2/ neu antibody and chemotherapeutic agents used for treatment of human breast cancers

    Mark Pegram;Sheree Hsu;Gail Lewis;Richard Pietras

  • A Central Role for HER3 in HER2-Amplified Breast Cancer: Implications for Targeted Therapy

    Si Tuen Lee-Hoeflich;Lisa Crocker;Evelyn Yao;Thinh Pham

  • Phase I Study of Trastuzumab-DM1, an HER2 Antibody-Drug Conjugate, Given Every 3 Weeks to Patients With HER2-Positive Metastatic Breast Cancer

    Ian E. Krop;Muralidhar Beeram;Shanu Modi;Suzanne F. Jones

  • Antibody therapeutics in cancer.

    Mark X. Sliwkowski;Ira Mellman

  • Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.

    Michael F. Press;Malcolm C. Pike;Victoria R. Chazin;Gene Hung

Frequent Co-Authors

Paul Polakis
Paul Polakis Genentech
Peter D. Senter
Peter D. Senter Seattle Genetics (United States)
Germaine Fuh
Germaine Fuh Genentech
Ira Mellman
Ira Mellman Parker Institute for Cancer Immunotherapy

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Students interested in Biology and Biochemistry can pursue a range of related online degrees for career advancement in healthcare, nutrition, and medical technology. Programs such as an online masters degree in nutrition offer flexible opportunities to specialize in areas that integrate biology and health, preparing graduates for roles in clinical nutrition and wellness.

If you are drawn to the medical imaging field, consider accredited online ultrasound tech school programs, which provide training in diagnostic sonography. Similarly, those seeking affordable education can explore the cheapest radiology tech programs, focused on essential radiologic skills and foundational science.

For advanced credentials, the top dietetics programs in the us blend rigorous biochemistry coursework with clinical applications, supporting careers in public health, nutrition, or research. Exploring these online degree and certification options can open a variety of pathways for those with a passion for biology and biochemistry.

Best Scientists Citing Mark X. Sliwkowski

Trending Scientists

Recently Published Articles